SINUVA J Code: J7402

Drug & Product Overview

HCPCS Descriptor Mometasone furoate sinus implant, (sinuva), 10 micrograms

HCPCS Added Date April 1, 2021

Manufacturer Intersect ENT

Route of Administration Intrasinal

Generic Status Single-Source; Branded

Dosage Form Implant

About SINUVA

Sinuva is a medication aligned to the HCPCS J Code: J7402 for billing, pricing, and reimbursement purposes in the United States. It is a Misc. drug administered via the intrasinal route and manufactured by Intersect ENT.

According to CMS Drug Use Information: Drug uses not available

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
10599-0003-01	Sinuva	Intersect ENT, Inc.	135	1350 UG

Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

SINUVA Pricing & Reimbursement

J7402 Private Payer Reimbursement

$11.26 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q4 2026

Mometasone Furoate 505(b)(2) Information:

HCPCS Code	Manufacturer	Active Ingredient	HCPCS Description
J7402	Intersect ENT	Mometasone Furoate	Mometasone furoate sinus implant, (sinuva), 10 micrograms

SINUVA Medically Unlikely Edits (MUE)

The most billing units of J7402 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 10 mcg.

Practitioner Office & Hospital Outpatient

270 units / day

= 2,700 mcg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

JW / JZ modifiers apply

CMS has identified Sinuva (J7402) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

SINUVA Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

chronic rhinosinusitis with nasal polyps

Drug Class

Corticosteroid Hormone Receptor Agonists [MoA]Corticosteroid [EPC]

Frequently Asked Questions

Is there an available Sinuva billing and coding guide?

Billing and coding information for SINUVA can be found through Intersect ENT. Visit Here →

Are there any available Sinuva patient assistance programs?

SINUVA patient assistance information can be found through Intersect ENT. Visit Here →

Where can I find Sinuva prescribing information?

SINUVA prescribing information can be found at the link below: Visit Here →

Where can I find Sinuva side effect information?

Our team has not yet identified a source of side effects information for SINUVA. Please check back in a few weeks.

Does billing SINUVA require JZ/JW wastage modifiers?

CMS has identified SINUVA(J7402) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.